Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Metastatic Colon Cancer
Status:
Terminated
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as gemcitabine and oxaliplatin work in different
ways to stop the growth of tumor cells, either by killing the cells or by stopping them from
dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells.
PURPOSE: This phase II trial is studying how well giving gemcitabine together with
oxaliplatin works as second-line therapy in treating patients with metastatic or recurrent
colon cancer.
Phase:
Phase 2
Details
Lead Sponsor:
University of Miami University of Miami Sylvester Comprehensive Cancer Center